Skip to content

Clinical trials

Phase 1/2 Stomach Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Clear all

252 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20022
20033
20044
20055
20061
20073
20085
20095
20103
20114
20123
20133
20148
20158
201611
201712
201818
201912
202021
202120
202225
202320
202414
202520
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Recruiting60
Unknown status44
Terminated32
Active, not recruiting27
Withdrawn10
Not yet recruiting7
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University9
Asan Medical Center6
AstraZeneca6
Amgen4
National Cancer Institute (NCI)4
Ruijin Hospital4
West China Hospital4
BioNTech SE3
Cancer Research UK3
Chongqing Precision Biotech Co., Ltd3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms252
Colorectal Neoplasms64
Carcinoma, Non-Small-Cell Lung57
Esophageal Neoplasms57
Pancreatic Neoplasms53
Ovarian Neoplasms46
Breast Neoplasms41
Melanoma36
Neoplasm Metastasis30
Endometrial Neoplasms26

Trials

Showing 51 to 75 of 252. Each trial links to its page on Pharma Observatory.

152 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.